Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

INTRODUCTION: To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and tolterodine extended release (ER) 4 mg results. METHODS: This prespecified pooled analysis of three ra...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nitti, V W, Khullar, V, Kerrebroeck, P, Herschorn, S, Cambronero, J, Angulo, J C, Blauwet, M B, Dorrepaal, C, Siddiqui, E, Martin, N E
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2013
Témata:
Urology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752932/
https://ncbi.nlm.nih.gov/pubmed/23692526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12194
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky